Ted Pellas, VMD, PhD, serves as the Executive Director and Imaging Lead for Oncology Clinical Development at GSK. Previously, they held senior roles at Novartis, Bristol-Myers Squibb, and AstraZeneca, leading pioneering efforts in clinical imaging and translational biomarker strategies across multiple oncology and immunology trials. Ted has a strong educational background, including a PhD in Experimental Pathology/Immunology from the University of Pennsylvania and a VMD from the same institution, along with master's and bachelor's degrees in Animal Physiology and Animal Science from Penn State University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices